News
Advertisement
Advertisement
Advertisement
The latest happenings of the industry in the past month.
Advertisement
The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.
Evolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
2
Real-World Evidence Is Moving Upstream: Is the Data Infrastructure Ready?
3
The Data Inputs That Matter Most When Pressure-Testing a Protocol's Feasibility
4
ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval
5